In this issue:
Rivaroxaban after transition from vitamin K antagonist
Apixaban vs. warfarin for stroke prevention in AF
Costs of stroke prevention in nonvalvular AF
Long-term dabigatran in AF
Repeat A&E visits in patients with AF
Alcohol intake and AF prognosis
Predicting progression in recently diagnosed AF
Benefits/risks of two dabigatran dosages vs. warfarin in AF
New ischaemic stroke/ thromboembolism prediction model for AF
Oral anticoagulation + clopidogrel in AF with drug-eluting stents
Please login below to download this issue (PDF)